Schizophrenia Research

Papers
(The TQCC of Schizophrenia Research is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia119
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK90
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia85
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis73
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength71
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life68
Going the extra mile? The influence of Amisulpride on effort-based decisions58
Searching for the “final proof” of schizophrenia54
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction54
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics51
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample47
Shortening telomere is associated with psychotic dimensions in the general population46
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments44
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia43
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia43
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis42
Frequency of clinical appointments in subjects with emergent suicidal ideation41
Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: A case report41
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans39
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study39
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 201739
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital38
Re-inventing the schizophrenia syndrome: The elusive “theory of everything”37
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis36
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?36
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data35
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?35
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment34
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia33
Denial of anosognosia in schizophrenia33
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective33
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences31
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma31
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience30
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders30
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults30
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis30
Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis28
Selection bias in clinical studies of first-episode psychosis: A follow-up study28
Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study28
Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics28
The potential of AI for scale development: A self-report psychosis symptoms measure using ChatGPT28
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?28
Interpersonal distance in schizophrenia: A systematic review27
Early cognitive development and psychopathology in children at familial high risk for schizophrenia27
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems27
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature26
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders26
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study26
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas26
Issue Highlights25
Meta-analysis of a family history of diabetes in schizophrenia25
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Res25
Abnormalities in motor adaptation to different types of perturbations in schizophreniaperturbations in schizophrenia25
A systematic review of dramatherapy interventions used to support adults with psychosis25
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit25
Arousal responses to personal space intrusions in psychotic illness: A virtual reality study24
Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia24
Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia24
Climatic exposures in childhood and the risk of schizophrenia from childhood to early adulthood24
Perceived burdensomeness and thwarted belongingness prospectively influence real-world social support-seeking behavior among emerging adults with first-episode psychosis23
Minority stress and schizophrenia-like experiences in sexual and gender minority adults23
Insomnia and substance use in psychotic disorders23
Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation23
Corrigendum to “Jang YJ, et al. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics” [Schizophr Res. 276 (2025) 88–96 10.1016/j.schres.2025.023
The infraslow fluctuation of sigma power during sleep in young individuals with schizophrenia23
Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia23
Determining the cumulative incidence of treated schizophrenia and predictors of transition in an early intervention for psychosis service22
Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls22
Personal recovery in first-episode psychosis: Beyond clinical and functional recovery22
Alteration in left frontoparietal connectivity correlates with impaired cognitive reappraisal in early psychosis22
Investigation on the association between perceived family expressed emotion, self-stigma, and subjective quality of life in people with early psychosis in Hong Kong: A cross-sectional approach22
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial22
The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms22
Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals22
Deciphering language disturbances in schizophrenia: A study using fine-tuned language models22
Brief video intervention to reduce stigma of family and friends of people living with serious mental illness22
Computational psychiatry and the psychopathology of psychosis: Promising leads and blind alleys21
A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts21
Relations of temporoparietal connectivity with neighborhood social fragmentation in youth at clinical high-risk for psychosis21
Schizophrenia among young people first admitted to psychiatric inpatient care during early and middle adolescence21
I am a person, not an illness21
Promoting implementation of deployment-ready psychosocial interventions21
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study21
Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia20
Clozapine discontinuation and rechallenge in suspected myocarditis: An analysis of seven cases20
Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophrenia20
Assessing negative symptoms of schizophrenia in the context of remote independent ratings: a psychometric evaluation of BNSS and PANSS20
The impact of early intervention for first episode psychosis on cognitive functioning20
Overview on cognitive impairment in psychotic disorders: From impaired microcircuits to dysconnectivity20
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study20
Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights19
Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models19
Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes19
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia19
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview19
Psychotic experiences predict subsequent loneliness among adolescents: A population-based birth cohort study19
Racial microaggressions and major discriminatory events explain ethnoracial differences in psychotic experiences19
Improving dependability in science: A critique on the psychometric qualities of the HiTOP psychosis superspectrum19
Factors and their weight in reducing life expectancy in schizophrenia19
Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia19
Acceptance and Commitment Therapy-based Lifestyle Counselling Program for people with early psychosis on physical activity: A pilot randomized controlled trial19
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity19
Issue highlights18
Redefining schizophrenia through genetics: A commentary on 50 years searching for biological causes18
Mitochondrial dysfunction in psychiatric disorders18
Reprint of Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study18
Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion18
Patient-reported outcome measures in early psychosis: A cross-cultural, longitudinal examination of the self-reported health and self-reported mental health measures in Chennai, India and Montreal, Ca18
Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?18
Increased prevalence of the Heschl's gyrus duplication pattern common to various first-episode psychoses17
Exploring the relationship between baseline health-related quality of life (AQoL-4D utility values) and mortality during long-term follow-up for people living with a psychotic disorder17
Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features17
Do you like cliff-hangers? Objective versus subjective need for closure in the schizophrenia spectrum17
Outcomes for first-episode psychosis after entry via an at-risk mental state clinic compared to direct entry to a first episode of psychosis service: A systematic review and meta-analysis17
Disparities in technology literacy and access negatively impact cognitive remediation scalability17
Aberrant salience predicts fluctuations of paranoia two weeks in advance during a 1-year experience sampling method study in people with psychosis17
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells17
Issue highlights17
Editorial Board17
Does affect mediate the relationship between interpersonal trauma and psychosis? A systematic review and meta-analysis17
Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self- experience16
Disrupted static and dynamic small-world brain network topologies in patients with schizophrenia16
Association between sleep disturbances and gray matter volume in individuals at clinical high-risk for psychosis and healthy controls: A longitudinal MRI study (NAPLS-3)16
Olfactory dysfunction in schizophrenia and other psychotic disorders: A comprehensive and updated meta-analysis16
The phenomenological nature of schizophrenia and disorder of selfhood16
Neurocognitive function and delusion severity in schizophrenia spectrum disorders16
MicroRNA-regulated suppression of some overexpressed genes in schizophrenia and their evolutionary significance16
Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia16
Response to the Letter to the editor: Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study16
Pathways linking adverse childhood experiences to psychosis risk in Lagos, Nigeria: A structural equation modeling approach16
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?16
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials16
Catatonia is associated with higher rates of negative affect amongst patients with schizophrenia and schizoaffective disorder16
Hippocampal volume in affective and non-affective psychosis16
Avolition predicts variability in optimal risk-taking in early psychosis16
Systematic review and meta-analysis of family-based interventions for early psychosis: Carer and patient outcomes16
Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies16
The diagnosis and treatment of catatonia via telemedicine: A case report and proposed diagnostic criteria16
Insight and suicidality in first-episode psychosis: The mediating role of depression16
Complex chronic conditions among children born to women with schizophrenia16
Functional network interactions in patients with schizophrenia with persistent auditory verbal hallucinations: A multimodal MRI fusion approach using three-way pICA15
Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes15
Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach15
Changes in social functioning over the course of psychotic disorders–A meta-analysis15
Renaming schizophrenia in Argentina: Could a change of name resolve the stigma? Results from a national survey15
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial15
The association between area-level factors and mortality in severe mental illnesses: A systematic review15
Food and nutrition insecurity among individuals with schizophrenia and related psychotic disorders15
Interoceptive functioning in schizophrenia and schizotypy15
Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London15
Sulfur-containing amino acids and risk of schizophrenia15
Associations between fearlessness about death and suicidal ideation in individuals with psychosis15
Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging15
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms15
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition14
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences14
Defeatist beliefs about performance are important treatment targets for negative symptoms in the early course of schizophrenia14
Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress14
Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept14
Subjective self-experiences at the mirror in patients with schizophrenia14
Editorial Board14
Insulin resistance and lipid levels in the middle-aged offspring of parents with severe mental illness14
Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study14
Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis14
Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls14
Highlights14
The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study14
Early improvement as a predictor of response to blonanserin transdermal patch in patients with schizophrenia14
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)14
Reshaping the diagnostic borders: Historical analysis of the diagnostic changes following the introduction of the schizophrenia concept14
Learning health systems in early interventions for psychosis: Establishing consumer voices in clinical high-risk for psychosis care14
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards14
Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats14
Editorial Board14
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone14
SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts14
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia14
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth14
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia13
Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure13
Evaluating the abnormal neural variability in schizophrenia: A TMS-EEG study13
Sleep patterns in treated and untreated patients of schizophrenia13
Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the whiteCAT study13
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia13
Initial evidence of vowel space reduction in a subset of individuals with schizophrenia13
Young first-episode psychosis patients exhibit impaired microvascular function in the skin and low systemic nitric oxide availability, independent of classical cardiovascular risk factors13
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report13
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia13
Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services13
The contributions of risk-taking and impulsivity to jumping to conclusions in the psychosis spectrum13
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia13
“The second I laid eyes on him I knew”: First impressions predict willingness to interact with individuals with schizophrenia13
Automatic identification of schizophrenia employing EEG records analyzed with deep learning algorithms13
Psychotic-like experiences in a nationally representative study of general population adolescents13
The role of defeatist performance beliefs on cognitive effort-cost decision-making in schizophrenia13
Longitudinal analysis of absolute neutrophil count (ANC) variability and neutropenia incidence in African American schizophrenia patients by ACKR1 genotype13
Catatonia is an outpatient reality. What do we do now?13
A useful construct to improve the lives of people with schizophrenia13
Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity13
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia12
Reply to dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges12
Everything is connected: Inference and attractors in delusions12
Why and how might yoga differ from other mind-body approaches in schizophrenia?12
Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?12
Self and time in individuals with schizophrenia: A motor component?12
Editorial Board12
Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia?12
Sub-clinical systemic inflammation as a determinant of admission duration in psychosis12
The unfulfilled promise of equitable first episode care for Black-Americans: A way forward12
Promoting safer and wider worldwide use of clozapine12
A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial12
Dynamic or not, here I come: Ambulatory assessment of psychomotor ability for clinical predictions12
Clozapine toxicity and coronavirus disease 2019: A case report12
Editorial Board12
Factor structure of social cognition in schizophrenia: Investigation of four core domains12
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capac12
Editorial Board12
Investigating bilirubin concentrations in schizophrenia: A systematic review and meta-analysis12
Predicting the onset of psychotic experiences in daily life with the use of ambulatory sensor data – A proof-of-concept study12
Abnormalities in emotion regulation are associated with negative, but not positive or disorganized schizotypy: An experience sampling study12
Retinal electrophysiological alterations are associated with cognition in early course psychosis12
Reframing schizophrenia: Altering our perceptions?12
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data11
The use of adaptive emotion regulation strategies in people with attenuated psychotic symptoms – Results from a two-week diary study11
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia11
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review11
The neuromuscular basis of functional impairment in schizophrenia: A scoping review11
Issue Highlights11
Access to cognitive remediation in Australia for people with schizophrenia11
Prenatal infection and schizophrenia: A decade of further progress11
Editorial Board11
Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia11
Epidemiology of psychotic-like experiences by subtypes and their relationship with emotional regulation and affective lability among Chinese college students11
‘Thinking about Them is only making me feel worse’. The mediating role of metacognitive factors in the relationship between paranoia-like beliefs and psychopathology symptoms in a community sample11
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition11
Clinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants11
Guidelines for the management of psychosis in the context of mood disorders11
Obsessive-compulsive symptoms and personal recovery in patients with schizophrenia spectrum disorders: A cross-sectional study11
Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders11
Long-term quality of life and social disconnection 20 years after a first episode psychosis, results from the 20-year follow-up of the OPUS trial11
Neuroanatomical subtypes of schizophrenia and relationship with illness duration and deficit status11
Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonan11
Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction11
Utilization of a psychosis consultation service: Early lessons from a statewide initiative11
Subtyping chronic catatonia: Clinical and neuropsychological characteristics of progressive periodic catatonia and chronic system catatonias vs. non-catatonic schizophrenia11
Hasty decision making and belief inflexibility in the more delusion prone? A modified disambiguating-scenarios paradigm assessing cognitive biases implicated in delusions11
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments11
How does attachment affect help-seeking in people with paranoia and psychosis? The role of emotion regulation, self-stigma, and perceived support10
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies10
0.1020200252533